Tobishima Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Tobishima Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11786
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tobishima Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Tobishima Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tobishima Corporation (Tobishima) is a provider of engineering and construction services. The company’s service portfolio includes contracting, planning, designing, development, property maintenance and restoration, renovation services, recycling services, contracting, consulting, repair, and damage mitigation. It also carries out civil engineering, disaster prevention training services, real estate leasing, and selling of residential properties. It serves medical facilities, sports facilities, hotels, restaurants, dams, residential buildings, tunnels, research institute, thermal power station, and office buildings. Key projects include Miyazaki Prefectural Arts Center, Sun Marine Stadium, Wacoal Headquarters Building, Sagae Dam and Urayama Dam. It undertakes projects in Japan, Brunei, Pakistan, Indonesia and Timor-Leste. Tobishima is headquartered in Chiyoda-ku, Tokyo, Japan.

Scope

- Detailed information on Tobishima Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tobishima Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Tobishima Corporation including a breakdown and examination of key business segments
- Intelligence on Tobishima Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tobishima Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tobishima Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tobishima Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tobishima Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Tobishima Corporation: Company Overview 7
Tobishima Corporation: Overview and Key Facts 7
Tobishima Corporation: Overview 7
Tobishima Corporation: Key Facts 7
Tobishima Corporation: Key Employees 9
Tobishima Corporation: Major Products and Services 10
Tobishima Corporation: Company History 11
Tobishima Corporation: Management Statement 13
Tobishima Corporation: Locations and Subsidiaries 14
Tobishima Corporation: Key Competitors 15
Tobishima Corporation: Company Analysis 16
Tobishima Corporation: Business Description 16
Tobishima Corporation: SWOT Analysis 17
Tobishima Corporation: SWOT Overview 17
Tobishima Corporation: Strengths 17
Tobishima Corporation: Weaknesses 18
Tobishima Corporation: Opportunities 18
Tobishima Corporation: Threats 19
Tobishima Corporation: Corporate Financial Deals Activity 21
Tobishima Corporation: Financial Deals Overview 21
Tobishima Corporation: Targets and Partners 23
Tobishima Corporation: Top Deals 2014 – 2018YTD* 24
Tobishima Corporation: Mergers and Acquisitions 25
Appendix 26
Contact Us 26
Methodology 26
About MarketLine 27

List of Tables
Table 1: Tobishima Corporation: Key Facts
Table 2: Tobishima Corporation: Key Employees
Table 3: Tobishima Corporation: Company History
Table 4: Tobishima Corporation: Locations and Subsidiaries
Table 5: Tobishima Corporation: Key Competitors
Table 6: Tobishima Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Tobishima Corporation: M&A Activity by Geography (TTM*)
Table 8: Tobishima Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Tobishima Corporation: Targets and Partners
Table 10: Tobishima Corporation: Top Deals 2014 - 2018YTD*
Table 11: Tobishima Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Tobishima Corporation: M&A Activity by Geography (2014 - YTD*2018)

List of Figures
Figure 1: Tobishima Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Tobishima Corporation: M&A Activity by Geography (TTM*)
Figure 3: Tobishima Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Tobishima Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Tobishima Corporation: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[Tobishima Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Double Bond Pharmaceutical International AB-製薬・医療分野:企業M&A・提携分析
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that develops and commercializes treatment of autoimmune diseases, cancers, infections, and other life-threatening disorders. The company’s products include proprietary platforms SA-033, SI-053, SA-042, and SA-083. …
  • Nh Foods Ltd
    Nh Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Nh Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Compass Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Compass Therapeutics LLC (Compass Therapeutics) is a biotechnology company that strives to develop transformational therapies for cancer, inflammation and autoimmune diseases. The company focuses on the discovery of antibody drug candidates that involve all targets in the complex immune func …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Swiss Life Holding Ltd:企業の戦略・SWOT・財務情報
    Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mgm China Holdings Ltd:企業の戦略・SWOT・財務分析
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Eversource Energy (ES)-エネルギー分野:企業M&A・提携分析
    Summary Eversource Energy (Eversource) is a utility holding company which operates energy delivery business through its subsidiaries. It transmits and distributes electricity and natural gas. The company sources electricity from its facilities, long-term power supply agreements, and competitive ener …
  • National Cancer Center Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis an …
  • Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive in …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務情報
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Extendicare Inc.:企業の戦略・SWOT・財務分析
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China CITIC Bank Corporation Limited:企業のM&A・事業提携・投資動向
    China CITIC Bank Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China CITIC Bank Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析
    Zhejiang Medicine Co Ltd (600216) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆